microdosing semaglutide vs tirzepatide GLP-1's for Weight Loss & Inflamation:-Dr Lipman, Miami Microdosing Tirzepatide and Semaglutide for

An interesting example of the probable use of the BPC 157 pentadecapeptide was presented in the US patent by Bentz et al

There are no large, randomized trials of injectable GHK-Cu

No, BPC-157 is not safe despite its claimed benefits

Importantly, these medications carry a boxed warning for risk of thyroid C-cell tumors and are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

An updated meta-analysis: Risk conferred by glutathione S-transferases (GSTM1 and GSTT1) polymorphisms to age-related cataract

This does not mean tirzepatide is contraindicated